Stay updated on Vorinostat and Azacitidine in MDS/AML Clinical Trial
Sign up to get notified when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.

Latest updates to the Vorinostat and Azacitidine in MDS/AML Clinical Trial page
- Check3 days agoChange DetectedA new site revision entry 'Revision: v3.5.4' appears in the history, replacing the previous 'Revision: v3.5.3'. This indicates a site update rather than a change to the study data or records.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThis updates the ClinicalTrials.gov page’s displayed revision/version number from v3.5.2 to v3.5.3, indicating a minor site build change rather than a modification to the study record.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded a new history entry (ID 143) dated 2026-04-13 with Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check39 days agoChange DetectedAdded multiple new history entries (versions 139–142) to the Record History, including recent Study Status updates.SummaryDifference0.4%

- Check47 days agoChange DetectedAdded recent entries 136–138 to the Record History, expanding the version history with additional status entries.SummaryDifference0.5%

- Check54 days agoChange DetectedAdded a Compare control and a Study Status field to the Record History page, along with new version entries dated 2026-03-24 to 2026-03-26. This enables easier side-by-side review of changes across versions.SummaryDifference88%

Stay in the know with updates to Vorinostat and Azacitidine in MDS/AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.